N. Seko

Omalizumab in Japanese children with severe allergic asthma uncontrolled with standard therapy.

M. Ebisawa, T. Fujisawa, S. Nishima, 2015, Allergology international : official journal of the Japanese Society of Allergology.

Secukinumab efficacy and safety in Japanese patients with moderate‐to‐severe plaque psoriasis: Subanalysis from ERASURE, a randomized, placebo‐controlled, phase 3 study

H. Nakagawa, Hidetoshi Takahashi, M. Ohtsuki, 2014, The Journal of dermatology.

Safety and effectiveness of secukinumab in psoriasis vulgaris and psoriatic arthritis: Real‐world evidence in Japan

M. Ohtsuki, H. Fujita, A. Morita, 2020, The Journal of dermatology.

Efficacy and safety of secukinumab in patients with generalized pustular psoriasis: A 52‐week analysis from phase III open‐label multicenter Japanese study

H. Nakagawa, M. Honma, M. Komine, 2016, The Journal of dermatology.

Efficacy and safety of canakinumab in systemic juvenile idiopathic arthritis: 48-week results from an open-label phase III study in Japanese patients

S. Takei, S. Yokota, N. Seko, 2020, Modern rheumatology.

Long-term safety, efficacy, pharmacokinetics and pharmacodynamics of omalizumab in children with severe uncontrolled asthma.

M. Ebisawa, T. Fujisawa, S. Nishima, 2017, Allergology international : official journal of the Japanese Society of Allergology.